GUERBET Vendor's profile

Guerbet announced today that the US Food and Drug Administration (FDA) has approved Dotarem® (gadoterate meglumine), a gadolinium-based contrast agent (GBCA) indicated for intravenous use with magnetic resonance imaging (MRI) in brain (intracranial), spine and associated tissues in adult and pe...


FDA Approves Lipiodol® (Ethiodized Oil) Injection for Imaging of Tumors in Adults with Known Hepatocellular Carcinoma (HCC) Princeton (NJ), Guerbet, a pioneer in the field of contrast agents for medical imaging announced that Lipiodol® was approved by the US Food and Drug Administration purs...


Villepinte, 12 November 2013 Guerbet LLC (USA) announced that Novation, the leading healthcare supply chain expertise, analytics and contracting company in the US, has awarded a new agreement for Dotarem® (gadoterate meglumine) Injection. Dotarem® is a gadolinium-based contrast age...


Contact GUERBET

Title *
Company / organisation *
Firstname *
Job title *
Lastname *
City *
E-mail *
Country *
Comment


All information that you supply is protected by our privacy policy.
In order to provide you with this free service, we may share your business information with companies whose content you choose to view on this website.
By submitting your information you agree to our Terms of Use. - See more at: IMAIOS privacy policy


To feature here :  Get in touch